[30] [31][32][33][34] [35][36][37][

[30] [31]
[32]
[33]
[34] [35]
[36]
[37]
[38] [39]
[40] [41]
[42]
[43] [44]
[45] [46]
9
R. M. Cohn and K. S. Roth, “Hyperammonemia, bane of the brain,” Clinical Pediatrics, vol. 43, no. 8, pp. 683–689, 2004. C. H. Dejong, W. J. Meijerink, C. L. van Berlo, N. E. Deutz, and P. B. Soeters, “Decreased plasma isoleucine concentrations after upper gastrointestinal haemorrhage in humans,” Gut, vol. 39, no. 1, pp. 13–17, 1996.
S. W. Olde Damink, C. H. Dejong, and R. Jalan, “Review article: hyperammonaemic and catabolic consequences of upper gastrointestinal bleeding in cirrhosis,” Alimentary Pharmacology and Therapeutics, vol. 29, no. 8, pp. 801–810, 2009.
K. Kisters, C. Spieker, S. Q. Nguyen, H. P. Bertram, C. Muller, and W. Zidek, “Zinc concentrations in human liver tissue and in blood plasma in cirrhosis of the liver due to alcoholism,” Trace Elements and Electrocytes, vol. 11, no. 3, pp. 101–103, 1994.
H. F. Goode, J. Kelleher, and B. E. Walker, “Relation between zinc status and hepatic functional reserve in patients with liver disease,” Gut, vol. 31, no. 6, pp. 694–697, 1990.
L. Capocaccia, M. Merli, C. Piat, R. Servi, A. Zullo, and O. Riggio, “Zinc and other trace elements in liver cirrhosis,” Italian Journal of Gastroenterology, vol. 23, no. 6, pp. 386–391, 1991.
K. Gohshi, S. Fujiyama, J. Shibata, T. Sato, A. Higashi, and I. Matsuda, “Zinc absorption and its correlation with results of oral zinc tolerance testing in non-alcoholic liver cirrhosis; kinetic study,” Hepatogastroenterology, vol. 42, no. 5, pp. 487– 491, 1995.
P. W. Keeling, W. Ruse, J. Bull, B Hannigan, and R. P. Thompson, “Direct measurement of the hepatointestinal extraction of zinc in cirrhosis and hepatitis,” Clinical Science, vol. 61, no. 4, pp. 441–444, 1981.
E. Rocchi, P. Borella, A. Borghi et al., “Zinc and magnesium in liver cirrhosis,” European Journal of Clinical Investigation, vol. 24, no. 3, pp. 149–155, 1994.
O. Riggio, M. Merli, L. Capocaccia et al., “Zinc supplemen- tation reduces blood ammonia and increases liver ornithine transcarbamylase activity in experimental cirrhosis,” Hepa- tology, vol. 16, no. 3, pp. 785–789, 1992.
A. S. Prasad, P. Rabbani, A. Abbasii, E. Bowersox, and M. R. Fox, “Experimental zinc deficiency in humans,” Annals of Internal Medicine, vol. 89, no. 4, pp. 483–490, 1978.
P. Reding, J. Duchateau, and C. Bataille, “Oral zinc sup- plementation improves hepatic encephalopathy. Results of a randomised controlled trial,” Lancet, vol. 2, no. 8401, pp. 493–495, 1984.
K. Gru ̈ngreiff, H. J. Presser, D. Franke, B. Lo ̈ssner, K. Abicht, and F. D. Kleine, “Correlations between zinc, amino acids and ammonia in liver cirrhosis,” Zeitschrift fur Gastroen- terologie, vol. 27, no. 12, pp. 731–735, 1989.
A. S. Prasad, “Effects of zinc deficiency on Th1 and Th2 cytokine shifts,” Journal of Infectious Diseases, vol. 182, no. 3, pp. S62–S68, 2000.
G. Marchesini, A. Fabbri, G. Bianchi, M. Brizi, and M. Zoli, “Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis,” Hepatology, vol. 23, no. 5, pp. 1084–1092, 1996.
P. Marchetti, P. Amodio, L. Caregaro, and A. Gatta, “Zinc deficiency in liver cirrhosis: a curiosity or problem?” Annali Italiani di Medicina Interna, vol. 13, no. 3, pp. 157–162, 1998. B. Dworkin, W. S. Rosenthal, R. H. Jankowski, G. G. Gordon, and D. Haldea, “Low blood selenium levels in alcoholics with and without advanced liver disease. Correlations with clinical

ผลลัพธ์ (ไทย) 3:

กระโดดเข้าไปในกระโดดเข้าไปในกระโดดเข้าไปในกระโดดเข้าไปในกระโดดเข้าไปในกระโดดเข้าไปในกระโดดเข้าไปในกระโดดเข้าไปในกระโดดเข้าไปในกระโดดเข้าไปใน